2017

Alector and AbbVie Announce Collaboration to Advance Immune Therapies for Patients with Alzheimer's Disease

PR Newswire, Oct 24, 2017

 

A company that's taking a new approach to tackling Alzheimer's just landed a $225 million endorsement

Business Insider, Oct 24, 2017

 

AbbVie antes up $225M in cash to buy into the Alzheimer’s platform at Alector

Endpoints News, Oct 24, 2017

 

Alzheimer's immunotherapy boosted by AbbVie deal

Financial Times, Oct 24, 2017

 

Could a New Immunotherapy Medical Approach Break the Alzheimer's Drug Curse?

Fortune, Oct 24, 2017

 

AbbVie Shells Out $205M Upfront for Alector's Antibodies Vs. Alzheimer's

Timmerman Report, Oct 24, 2017

 

AbbVie bets on Alzheimer's immunotherapy with big biotech deal

Reuters, Oct 24, 2017

 

AbbVie, Alector pair for Alzheimer’s in $205M pact

FierceBiotech, Oct 24, 2017

 

With new approach to Alzheimer's, Peninsula company seals $225M deal with drug giant AbbVie

San Francisco Business Times, Oct 24, 2017

 

AbbVie invests in Alector’s immunoneurology therapies for Alzheimer’s

Chemical and Engineering News, Oct 24, 2017

 

Full-court Press by Alector: Neuro-immunology effort draws $205M from AbbVie

BioWorld, Oct 25, 2017


 

2016

The Road Less Traveled: Start-ups invest in novel approaches against neurodegeneration.

Nature Medicine, 22, 11-13 (2016)

 

Dementia Discovery Fund Chooses Alector for First Investment

Wall Street Journal, Jan 7, 2016


 

2015

Fierce Biotech’s 2015 Fierce 15

FierceBiotech

 

Google, OrbiMed buy into Alector’s novel take on Alzheimer’s with a $32M round

FierceBiotech, Sept 16, 2015

 

Alector Raises $32M for Immune-Based Neuro Drug Development

Xconomy, Sept 16, 2015


 

2014

Top 30 Life Science Startups to Watch in the US

BioSpace, Oct 23, 2014


 

2013

‘Alector’ See Alzheimer’s Beat: Series A to Fund Antibody Bid

BioWorld Today, Nov 1, 2013

 

The Daily Startup: Alector Seeks Cure for Alzheimer’s Disease

Wall Street Journal, Oct 31, 2013

 

Alector snags funding in founder’s latest attack on Alzheimer’s

San Francisco Business Times, Oct 31, 2013

 

Alector Goes After Alzheimer’s, With Cash from Polaris and OrbiMed

Xconomy, Oct 31, 2013

 

Alzheimer’s experts team up with Adimab, grab $10M to launch Alector

FierceBiotech, Oct 30, 2013